303 A Phase I Study of the HDM2 Antagonist SAR405838 Combined with the MEK Inhibitor Pimasertib in Patients with Advanced Solid Tumors
European journal of cancer(2015)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined